# 健康保険法 / Health Insurance Act — 第二条 (Supplementary Provisions, Article 2)

- Law: 健康保険法 (Health Insurance Act), 大正十一年法律第七十号
- English title "Health Insurance Act": Ministry of Justice translation
- Kind: Act — the distinction between 法律 (Act), 政令 (Cabinet Order), 省令 (Ministerial Order) and 条例 (local ordinance) decides who may issue it and what it may say.
- Provision: 第二条 (Supplementary Provisions, Article 2)（検討） — address `suppl-5041-96/art-2`
- Text in force since: 2026-10-01
- URL (the page that opens at this provision): https://japanlaw.org/ja/health-insurance-act/suppl-5041-96/art-2
- Permanent URL (e-Gov law ID, never renamed): https://japanlaw.org/l/211AC0000000070/suppl-5041-96/art-2
- Every provision below carries its address and both URLs on the line under it.
- Japanese text: e-Gov 法令検索, Digital Agency (デジタル庁). English: as marked on each line below.

Only the Japanese as published by the government has legal effect; the text
below is a copy of it. Every English rendering below is a translation and
says which kind: the Ministry of Justice's translation, or this
site's machine translation, whose model and date the Sources list names.
They are never merged and never substituted for one another.

---

### 第二条（検討） — Review
<sup>caption: machine translation, not official</sup>
<sup>suppl-5041-96/art-2 · https://japanlaw.org/ja/health-insurance-act/suppl-5041-96/art-2 · https://japanlaw.org/l/211AC0000000070/suppl-5041-96/art-2</sup>

**第一項**  政府は、新型コロナウイルス感染症（病原体がベータコロナウイルス属のコロナウイルス（令和二年一月に、中華人民共和国から世界保健機関に対して、人に伝染する能力を有することが新たに報告されたものに限る。）であるものに限る。以下同じ。）の罹患後症状に係る医療の在り方について、科学的知見に基づく適切な医療の確保を図る観点から速やかに検討を加え、その結果に基づいて必要な措置を講ずるものとする。
<sup>suppl-5041-96/art-2/par-1 · https://japanlaw.org/ja/health-insurance-act/suppl-5041-96/art-2/par-1 · https://japanlaw.org/l/211AC0000000070/suppl-5041-96/art-2/par-1</sup>
The government is to promptly examine the state of medical care for post-infection symptoms of novel coronavirus infectious disease (limited to those whose pathogen is a coronavirus of the genus Betacoronavirus (limited to one that, in January 2020, was newly reported by the People's Republic of China to the World Health Organization as having the capacity to be transmitted to humans); the same applies hereinafter), from the viewpoint of ensuring appropriate medical care based on scientific knowledge, and take necessary measures based on the results.
<sup>machine translation, not official</sup>

**第二項**  政府は、新型コロナウイルス感染症に関する状況の変化を勘案し、当該感染症の新型インフルエンザ等感染症（感染症法第六条第七項に規定する新型インフルエンザ等感染症をいう。附則第六条において同じ。）への位置付けの在り方について、感染症法第六条に規定する他の感染症の類型との比較等の観点から速やかに検討を加え、その結果に基づいて必要な措置を講ずるものとする。
<sup>suppl-5041-96/art-2/par-2 · https://japanlaw.org/ja/health-insurance-act/suppl-5041-96/art-2/par-2 · https://japanlaw.org/l/211AC0000000070/suppl-5041-96/art-2/par-2</sup>
Taking into account changes in the situation concerning novel coronavirus infectious disease, the government is to promptly examine how that infectious disease is to be positioned as a novel influenza, etc. infectious disease (meaning the novel influenza, etc. infectious disease prescribed in Article 6, paragraph (7) of the Infectious Diseases Control Act; the same applies in Article 6 of the Supplementary Provisions), from the viewpoint of comparison with the other types of infectious diseases prescribed in Article 6 of that Act, and take necessary measures based on the results.
<sup>machine translation, not official</sup>

**第三項**  政府は、予防接種の有効性及び安全性に関する情報（副反応に関する情報を含む。）の公表の在り方について検討を加え、その結果に基づいて必要な措置を講ずるものとする。
<sup>suppl-5041-96/art-2/par-3 · https://japanlaw.org/ja/health-insurance-act/suppl-5041-96/art-2/par-3 · https://japanlaw.org/l/211AC0000000070/suppl-5041-96/art-2/par-3</sup>
The government is to examine how information on the efficacy and safety of vaccinations (including information on adverse reactions) is to be made public, and take necessary measures based on the results.
<sup>machine translation, not official</sup>

**第四項**  政府は、この法律の施行後五年を目途として、この法律による改正後のそれぞれの法律（以下この項において「改正後の各法律」という。）の施行の状況等を勘案し、必要があると認めるときは、改正後の各法律の規定について検討を加え、その結果に基づいて所要の措置を講ずるものとする。
<sup>suppl-5041-96/art-2/par-4 · https://japanlaw.org/ja/health-insurance-act/suppl-5041-96/art-2/par-4 · https://japanlaw.org/l/211AC0000000070/suppl-5041-96/art-2/par-4</sup>
The government is to, with a target of five years after the enforcement of this Act, taking into account the conditions of enforcement, etc. of the respective Acts as amended by this Act (referred to as "the respective Acts as amended" in this paragraph), examine the provisions of the respective Acts as amended where it finds it necessary, and take required measures based on the results.
<sup>machine translation, not official</sup>

---

## Cites
- suppl-5041-96/art-2/par-4: この項 → 健康保険法 附則第二条第四項 (Supplementary Provisions, Article 2, paragraph (4)), suppl-5041-96/art-2/par-4 — https://japanlaw.org/ja/health-insurance-act/suppl-5041-96/art-2/par-4 · https://japanlaw.org/l/211AC0000000070/suppl-5041-96/art-2/par-4

## Cited by

2 provisions cite this one. No official source publishes this direction.

- 健康保険法 附則第一条第一項第一号（施行期日） — https://japanlaw.org/ja/health-insurance-act/suppl-5041-96/art-1/par-1/item-1 · https://japanlaw.org/l/211AC0000000070/suppl-5041-96/art-1/par-1/item-1
- 健康保険法 附則第二条第四項（検討） — https://japanlaw.org/ja/health-insurance-act/suppl-5041-96/art-2/par-4 · https://japanlaw.org/l/211AC0000000070/suppl-5041-96/art-2/par-4

---

## Sources

- e-Gov 法令検索, Digital Agency (デジタル庁) — 健康保険法 — the text in force from 2026-10-01 (https://laws.e-gov.go.jp/law/211AC0000000070/20261001_507AC0000000087), retrieved 2026-10-10
- Japanese Law Translation Database System, Ministry of Justice (法務省) — Health Insurance Act — Ministry of Justice translation (https://www.japaneselawtranslation.go.jp/en/laws/view/3266/tb), retrieved 2026-10-10
- claude-sonnet-5-5 — Machine translation, batch health-insurance-act-20261010T183826-039, translated 2026-10-11
- This site's parser, version 189 — 健康保険法 — structure, counts, cross-references and defined terms, computed 2026-10-10
